2023年美国血液学会(ASH)血液病免疫疗法峰会

2023年美国血液学会(ASH)血液病免疫疗法峰会将于2023年3月1日至3日在美国华盛顿举行，会议由美国血液学会(ASH)主办。通过参加本次会议，与会者可以：了解免疫疗法的现状及其在血液系统疾病中的应用；深入了解联合疗法在血液疾病治疗中的应用；了解免疫疗法在临床实践中的监管和实施；更好地了解利用细胞疗法治疗非恶性和病毒相关血液病；讨论对后期免疫治疗临床试验设计至关重要的科学、临床和监管方面的问题；等等。

美国血液学会（ASH）成立于1958年，是世界上最大的关注血液疾病病因与治疗的专业学会，在全球近100个国家拥有超过17,000名成员，ASH为世界各地致力于治疗血液疾病的临床医生和科学家服务。ASH通过促进宣对血液学的研究、临床护理、教育、培训和宣传，进而促进对血液、骨髓、免疫、止血和血管系统疾病的了解、诊断与防治。

ASH Summit on Immunotherapies for Hematologic Diseases 2023
Date: March 1-3, 2023
Venue: Washington, DC, USA

Why is the success of immunotherapies and other targeted therapies such as gene therapy so variable within different patient populations? How can we improve these targeted therapies for widespread use in patients with hematologic diseases? Help answer these questions and more at the ASH Summit on Immunotherapies for Hematologic Diseases.

This in-person Summit is a unique meeting of the minds among the academic, medical, industry, and federal regulatory communities to address the obstacles in immunotherapy treatment development for non-malignant and malignant hematologic conditions. Whether you’re a career or trainee researcher or clinician, industry professional, or federal regulator, you won’t want to miss this unique opportunity to share ideas! Through participation in this meeting, attendees will be able to:

• Discuss fundamental advances in basic immunology that provide the foundation for immune therapies and their application
• Gain insights into critical limitations of immunotherapies and gene therapy including associated adverse events
• Examine cellular and molecular mechanisms involved in resistance and relapse associated with these therapies
• Review new immunotherapy targets
• Discuss the application of CRISPR gene editing in the development of targeted therapies
• Analyze cell manufacturing considerations
• Learn about the application of immunotherapies for the treatment of both non-malignant hematologic and malignant diseases

Target Audience

The ASH Summit on Immunotherapies for Hematologic Diseases is designed to provide a wide set of learning and networking opportunities for experts in hematology, including:

• Laboratory-based scientists
• Translational and clinical researchers
• Practitioners interested in the application of immunotherapies
• Young investigators (trainees)
• Cellular therapy, gene therapy, biopharmaceutical, and life sciences industry experts
• Regulatory scientists

会议对象: 医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。